Pharmaceutical Technology\'s In the Lab eNewsletter-05-01-2019

To achieve high-quality pharmaceutical product, it is important to characterize the drug particles and understand the behavior of bulk powder.

Glycosylation modeling is a useful tool for determining biopharma product quality, and establishing collaboration between academic and industrial groups ensures that such modeling tools are fit for use.

The EXcell 231 and EXcell 241 sensors from EXNER Process Equipment have updated software and connection features for improved flexibility and safety.

Cygnus Technologies has developed the EndonucleaseGTP ELISA Kit to quantitate and detect residual endonuclease impurities in recombinant vaccines and viral vectors used for gene therapy.

Lonza’s fully automated plate-based PyroTec PRO Robotic Solution accelerates endotoxin testing of parenteral pharmaceuticals.

University of Southern California scientists have made an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings.

Cambrex’s expanded quality control laboratory supports generic API development.

The agency provides recommendations for the development of bispecific antibody development programs that include regulatory, quality, nonclinical, and clinical considerations.

The companies will merge to offer a broader range of analytical data packages and regulatory support for biopharmaceuticals.

The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.

3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom